IRIX
IRIDEX CorporationNASDAQ
Healthcare • Medical Devices
$0.66-3.32%
Close Nov 6, 2026
- Market cap
- $11.42M
- 1 month
- -26.8%
- 3 months
- -21.9%
- 1 year
- -37.1%
- 52-week range
- $0.61$1.56
- Dividend
- No dividends on record
- Short interest
- 1.5% of float76.2K shares · settled Oct 15, 2026 · -42.1% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $51.57M
- Net income
- -$3.55M
- Free cash flow
- -$1.85M
- Book value
- $3.64M
- Total debt
- $4.01M
- P/E
- —
- Price / sales
- 0.2×
- Price / book
- 3.1×
- FCF yield
- -16.2%
- Net margin
- -6.9%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Read more
It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. In addition, it offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform transscleral laser therapy; G-Probe and G-Probe Illuminate, which are used in procedures to treat uncontrolled and refractory glaucoma; and EndoProbe family of products that are used for endophotocoagulation. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics through direct and independent sales force in the United States, as well as through independent distributors internationally. It operates in the United States, Europe, the Middle East, Africa, the Asia/Pacific region, and the Americas. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.
- Website
- iridex.com
- Headquarters
- Mountain View, CA, United States
- Employees
- 93
- Listed
- Feb 15, 1996
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 6, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 18, 2026 | $12.6M | -7.4% | 34.2% | -$1.0M | -$1.3M |
| Mar 2026filed May 19, 2026 | $11.8M | -0.8% | 40.2% | -$324.0K | -$524.0K |
| Dec 2025filed Mar 13, 2026 | $14.7M | +16.0% | 38.3% | -$15.0K | -$184.0K |
| Sep 2025filed Nov 12, 2025 | $12.5M | +7.8% | 32.1% | -$1.4M | -$1.6M |
| Jun 2025filed Aug 12, 2025 | $13.6M | +7.4% | 33.9% | -$940.0K | -$994.0K |
| Mar 2025filed May 13, 2025 | $11.9M | +1.1% | 42.5% | -$205.0K | -$1.7M |
| Dec 2024filed Mar 27, 2025 | $12.7M | +1.9% | 44.0% | -$502.0K | -$834.0K |
| Sep 2024filed Nov 12, 2024 | $11.6M | -9.9% | 37.3% | -$1.9M | -$1.9M |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Apr 2, 2026 | $52.7M | +8.2% | 36.7% | -$2.6M | -$4.4M |
| Dec 2024filed Mar 27, 2025 | $48.7M | -6.2% | 40.1% | -$8.3M | -$8.9M |
| Dec 2023filed Mar 29, 2024 | $51.9M | -9.0% | 42.0% | -$10.0M | -$9.6M |
| Dec 2022filed Mar 9, 2023 | $57.0M | +5.7% | 44.5% | -$7.5M | -$7.5M |
| Dec 2021filed Mar 15, 2022 | $53.9M | +48.3% | 42.4% | -$7.5M | -$5.2M |
| Dec 2020filed Mar 23, 2021 | $36.3M | -16.3% | 42.8% | -$6.6M | -$6.3M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched IRIX. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
76,195 shares short
-55,460 shares (-42.1%) vs Sep 30, 2026
1.5% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
131,655 shares short
-28,675 shares (-17.9%) vs Sep 15, 2026
2.5% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
160,330 shares short
+12,019 shares (+8.1%) vs Aug 31, 2026
3.1% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
148,311 shares short
+110,457 shares (+291.8%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
37,854 shares short
+8,690 shares (+29.8%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
29,164 shares short
-6,898 shares (-19.1%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind IRIX’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if IRIX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
5 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Insider context
Sentiment: bullish
Last trade: buy 31 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 7
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
29 filers reported a long position in IRIX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
86.5%
of the 2.2M shares 13-F filers reported
Moves vs Q1 2026
4 added2 trimmed
1 new · 3 unchanged
Net shares held
-1.1%
across the 9 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | $589.2K · 514.6K shares | 514.6K | Unchanged |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $485K · 423.5K shares | 423.5K | +6.8% |
| 3 | MORGAN STANLEY | $349.4K · 305.2K shares | 305.2K | New |
| 4 | WEBER CAPITAL MANAGEMENT LLC /ADV | $206.6K · 180.5K shares | 180.5K | -30.5% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | $159.2K · 139K shares | 139K | -13.2% |
| 6 | CITADEL ADVISORS LLC | $113.3K · 99K shares | 99K | +62.6% |
| 7 | PERKINS CAPITAL MANAGEMENT INC | $81.1K · 70.8K shares | 70.8K | +28% |
| 8 | VANGUARD FIDUCIARY TRUST CO | $68.9K · 60.2K shares | 60.2K | Unchanged |
| 9 | STATE STREET CORP | $51.2K · 44.7K shares | 44.7K | Unchanged |
| 10 | GOLDMAN SACHS GROUP INC | $46.3K · 40.5K shares | 40.5K | +7.5% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of IRIX file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Jul 13, 2026 | Novel Inspiration International Co., Ltd.13D · activist · amended | 29.92% |
Get the Full Analysis for IRIX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.